BioLASCO Taiwan Co

BioLASCO Taiwan Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BioLASCO Taiwan Co (6662.TWO) as of Nov 4, 2026 is 49.99 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 55.71 M TWD — a change of -10.27% (lower).

EBITDA

49.99 MTWD

YoY

-10.27%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BioLASCO Taiwan Co is 2025 49.99 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BioLASCO Taiwan Co was 2024 55.71 M TWD. It decreases by -10.27% lower compared to the previous year.

The BioLASCO Taiwan Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
68.75 M TWD
Jan 1, 2019
70.88 M TWD
Jan 1, 2020
77.57 M TWD
Jan 1, 2021
56.85 M TWD
Jan 1, 2022
53.49 M TWD
Jan 1, 2023
50.81 M TWD
Jan 1, 2024
55.71 M TWD
Jan 1, 2025
49.99 M TWD
The BioLASCO Taiwan Co EBITDA history
YEAREBITDAYoY
49.99 MTWD-10.27%
55.71 MTWD+9.64%
50.81 MTWD-5.01%
53.49 MTWD-5.91%
56.85 MTWD-26.71%
77.57 MTWD+9.44%
70.88 MTWD+3.10%
68.75 MTWD-0.88%
69.36 MTWD+31.01%
52.94 MTWD-2.97%
54.56 MTWD+4.49%
52.22 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BioLASCO Taiwan Co Stock analysis

What does BioLASCO Taiwan Co do? BioLASCO Taiwan Co Ltd operates in the Health Care sector, specializing in Life Sciences Tools & Services. Based in Taipei City, the company produces and sells specific pathogen-free experimental mice and rats, including inbred strains and immune-deficient models. It also offers related equipment for feeding, supplies, and testing platforms, alongside life science research and pharmaceutical development services. Listed on 4 January 2018, BioLASCO Taiwan focuses on supporting biomedical research and drug development. BioLASCO Taiwan Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioLASCO Taiwan Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BioLASCO Taiwan Co is 49.99 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BioLASCO Taiwan Co changed from 55.71 M TWD to 49.99 M TWD, representing a -10.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) BioLASCO Taiwan Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s BioLASCO Taiwan Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — BioLASCO Taiwan Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — BioLASCO Taiwan Co